Stay updated on mFOLFIRINOX +/- Ramucirumab Clinical Trial

Sign up to get notified when there's something new on the mFOLFIRINOX +/- Ramucirumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the mFOLFIRINOX +/- Ramucirumab Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Locations are reorganized under a new top-level 'Locations' section with state subsections (Arizona, Georgia, Indiana, Kentucky, Nebraska, Pennsylvania), replacing the prior per-state location blocks. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-12-23T22:46:15.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The Publications section now notes that entries are automatically filled from PubMed, and the revision label changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:28:55.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The site-wide banner about government funding and operating status has been removed. Study details and eligibility criteria remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:27:14.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    No significant additions or removals are detected. The page remains focused on the study overview, eligibility criteria, and locations.
    Difference
    0.4%
    Check dated 2025-10-27T20:59:28.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.
    Difference
    3%
    Check dated 2025-10-06T08:13:06.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.
    Difference
    0.4%
    Check dated 2025-09-29T04:47:48.000Z thumbnail image

Stay in the know with updates to mFOLFIRINOX +/- Ramucirumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the mFOLFIRINOX +/- Ramucirumab Clinical Trial page.